I agree that this site is using cookies. You can find further informations here.
X
Shaligram, Umesh
80  results:
Search for persons X
?
1

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): ..:

Kulkarni, Prasad S. ; Padmapriyadarsini, Chandrasekaran ; Vekemans, Johan...
Human Vaccines & Immunotherapeutics.  20 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
2

Validation and Suitability Assessment of Multiplex Mesoscal..:

Shengule, Sushant ; Alai, Shweta ; Bhandare, Sachin...
Vaccines.  12 (2024)  4 - p. 433 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Safety and efficacy of malaria vaccine candidate R21/Matrix..:

Datoo, Mehreen S ; Dicko, Alassane ; Tinto, Halidou...
The Lancet.  403 (2024)  10426 - p. 533-544 , 2024
Link: https://doi.org/10.1016/..
 
?
4

A Combined LC-MS and Immunoassay Approach to Characterize P..:

Caringal, Ria T. ; Hickey, John M. ; Sharma, Nitya...
Vaccines.  12 (2024)  6 - p. 580 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Immunogenicity and safety of a new quadrivalent HPV vaccine..:

Sharma, Hitt ; Parekh, Sameer ; Pujari, Pramod...
The Lancet Oncology.  24 (2023)  12 - p. 1321-1333 , 2023
Link: https://doi.org/10.1016/..
 
?
6

A phase-I, open label clinical trial to assess the safety &..:

Sharma, Hitt ; Anil, K. ; Parekh, Sameer...
Vaccine: X.  14 (2023)  - p. 100313 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Multiplexed bead-based assay for the simultaneous quantific..:

Rathod, Vishal ; Kadam, Laxmikant ; Gautam, Manish...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

A Phase 3, randomized, non-inferiority study of a heterolog..:

Kulkarni, Prasad S. ; Gunale, Bhagwat ; Kohli, Sunil...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
9

A Phase I study to evaluate safety and tolerability of DTaP..:

Sharma, Hitt ; Marthak, Kiran ; Parekh, Sameer...
Vaccine: X.  14 (2023)  - p. 100300 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Multi-Dose Formulation Development for a Quadrivalent Human..:

Jerajani, Kaushal ; Wan, Ying ; Kumru, Ozan S....
Journal of Pharmaceutical Sciences.  112 (2023)  2 - p. 446-457 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Safety and immunogenicity of an indigenously developed teta..:

Sharma, Hitt J ; Parekh, Sameer ; Pujari, Pramod...
Expert Review of Vaccines.  22 (2023)  1 - p. 278-287 , 2023
Link: https://doi.org/10.1080/..
 
?
12

Development and validation of capillary electrophoresis sod..:

Thorat, Shrikant ; Ogale, Pratik ; Gautam, Manish..
Vaccine.  41 (2023)  40 - p. 5854-5862 , 2023
Link: https://doi.org/10.1016/..
 
?
13

The 100 Days Mission: how a new medical-countermeasures net..:

Dzau, Victor ; Swaminathan, Soumya ; Baker, Charlotte...
The Lancet.  402 (2023)  10412 - p. 1507-1510 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Multi-dose Formulation Development for a Quadrivalent Human..:

Sharma, Nitya ; Jerajani, Kaushal ; Wan, Ying...
Journal of Pharmaceutical Sciences.  112 (2023)  2 - p. 458-470 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Large-Scale Purification and Characterization of Recombinan..:

Nagar, Gaurav ; Jain, Siddharth ; Rajurkar, Meghraj...
Vaccines.  11 (2023)  10 - p. 1602 , 2023
Link: https://doi.org/10.3390/..
 
1-15